White Spot Disease (Liver Fluke) - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 7 min read ✅ Medically reviewed
```html White Spot Disease (Liver Fluke) – Complete Medical Guide

Overview

White spot disease, more correctly called liver fluke infection or fascioliasis, is a parasitic disease caused by flatworms of the genus Fasciola (most commonly Fasciola hepatica and, less often, Fasciola gigantica). The parasites live in the bile ducts of the liver, where they cause inflammation, obstruction, and characteristic “white spots” that can be seen on imaging studies.

The disease is most common in areas where livestock (sheep, cattle, goats) graze on wet pastures and where people consume raw or under‑cooked aquatic plants (watercress, wild lettuce, etc.) that harbor the infective stage of the fluke. Endemic regions include:

  • South America (Argentina, Chile, Peru)
  • Europe (parts of the United Kingdom, Spain, France)
  • Africa (Ethiopia, Kenya, Tanzania)
  • Asia (China, Iran, Vietnam, India)

Worldwide, the World Health Organization estimates that 2.4–17 million people are infected, with the highest burden in the Andean highlands of South America.1 In the United States, cases are rare and usually linked to travel or immigration from endemic areas.2

Symptoms

The clinical picture of fascioliasis is classically divided into three phases: the incubation/penetration phase, the acute (hepatic) phase, and the chronic (biliary) phase. Not everyone experiences every symptom, and the intensity often depends on the number of flukes and the host’s immune response.

Incubation / Penetration Phase (2–8 weeks after ingestion)

  • Abdominal discomfort: vague pain in the upper right quadrant as larvae migrate through the peritoneum.
  • Fever & chills: low‑grade to moderate fevers (37.5–39 °C).
  • Skin rash or urticaria: hypersensitivity reaction to migrating larvae.
  • Headache & malaise: general feeling of being unwell.

Acute (Hepatic) Phase (4–12 weeks after infection)

  • Severe right‑upper‑quadrant pain: due to liver capsule distension.
  • Fever with chills (often > 38 °C).
  • Nausea, vomiting, loss of appetite.
  • Jaundice: yellowing of skin and eyes if bile flow is obstructed.
  • Elevated liver enzymes: ALT, AST, ALP, and GGT.
  • Eosinophilia: blood count shows high eosinophils (often > 1,500 cells/µL).
  • Diarrhea or dysentery: occasional, due to irritation of the intestine.

Chronic (Biliary) Phase (months to years)

  • Persistent right‑upper‑quadrant or epigastric pain.
  • Intermittent jaundice and pruritus (itching).
  • Fatigue and weight loss.
  • Gallstone‑like symptoms: biliary colic, cholangitis, or pancreatitis.
  • Anemia: due to chronic inflammation or occult blood loss.
  • Hepatomegaly: enlarged liver palpable on exam.
  • White‑spot lesions on imaging: multiple hypodense lesions on CT or MRI, giving the disease its colloquial name.

Causes and Risk Factors

Fasciola flukes have a complex life cycle involving two intermediate hosts (snails and aquatic plants) and a definitive host (livestock or humans).

  1. Ingestion of metacercariae: The infective cyst stage adheres to watercress, lettuce, or other freshwater greens. Eating these raw or poorly washed is the primary route.
  2. Contaminated water: Drinking unboiled water containing free metacercariae can also cause infection.

Key Risk Factors

  • Living or working in rural, agricultural settings where livestock graze on wet pastures.
  • Frequent consumption of raw aquatic vegetables—especially watercress, taro leaves, or other freshwater greens.
  • Occupations involving close contact with snails or flooded fields (e.g., herders, rice farmers).
  • Travel to endemic regions without taking food‑safety precautions.
  • Immunocompromised states (HIV, chemotherapy) may increase disease severity.

Diagnosis

Because the early symptoms mimic many other hepatic or gastrointestinal disorders, a high index of suspicion is essential, especially in travelers or residents from endemic areas.

Laboratory Tests

  • Complete blood count (CBC): marked eosinophilia is a hallmark (often > 10% of white cells).
  • Liver function tests (LFTs): elevated ALT, AST, alkaline phosphatase, and bilirubin.
  • Stool microscopy: detection of Fasciola eggs (3‑5 mm, operculated) is the gold standard but may be negative in the early phase.
  • Serologic tests: ELISA or indirect hemagglutination for Fasciola‑specific antibodies; useful before eggs appear in stool.
  • PCR assays: increasingly available in reference labs for species identification.

Imaging Studies

  • Ultrasound: may show hypoechoic lesions, bile duct dilation, or “white spots.”
  • CT scan: characteristic low‑attenuation nodules (often 5‑10 mm) scattered throughout the liver.
  • Magnetic Resonance Imaging (MRI): provides detailed biliary mapping; useful before surgical interventions.

Diagnostic Criteria (per WHO)

  1. History of exposure (raw aquatic plants, travel to endemic area).
  2. Clinical presentation compatible with fascioliasis.
  3. Laboratory evidence (eosinophilia + positive serology or stool ova).
  4. Imaging supportive of hepatic lesions.

Treatment Options

The cornerstone of therapy is antiparasitic medication; surgery or endoscopic procedures are reserved for complications.

First‑Line Medications

  • Triclabendazole (Egaten®): 10 mg/kg as a single dose; a repeat dose after 12–24 hours may be given if the initial response is inadequate. It is highly effective against both immature and adult flukes (cure rates > 90%).3
  • Bithionol: 30 mg/kg three times daily for 30 days; used where triclabendazole is unavailable, but associated with more gastrointestinal side effects.

Alternative / Adjunctive Therapy

  • Praziquantel: not reliably effective against Fasciola but may be used for mixed‑infection settings.
  • Corticosteroids: short courses (e.g., prednisone 0.5 mg/kg) can alleviate severe eosinophilic inflammation during the acute phase.

Procedural Interventions

  • Endoscopic Retrograde Cholangiopancreatography (ERCP): removal of flukes obstructing the common bile duct.
  • Laparoscopic or open surgery: indicated for massive biliary obstruction, cholangitis unresponsive to antibiotics, or when flukes form large masses.
  • Percutaneous drainage: for hepatic abscesses secondary to fluke migration.

Lifestyle & Supportive Care

  • Hydration and a balanced diet to support liver regeneration.
  • Analgesics (acetaminophen or short courses of NSAIDs) for pain.
  • Antibiotics if secondary bacterial cholangitis is suspected (e.g., ceftriaxone).

Living with White Spot Disease (Liver Fluke)

Even after successful treatment, some individuals experience lingering fatigue or mild biliary irritation. Practical steps can improve quality of life.

Daily Management Tips

  • Follow-up labs: repeat CBC and LFTs 2–4 weeks after therapy to confirm resolution of eosinophilia and liver enzyme normalization.
  • Maintain a liver‑friendly diet: avoid excessive alcohol, fried foods, and high‑fat meals that can stress the biliary system.
  • Stay hydrated: adequate fluid intake promotes bile flow.
  • Exercise gently: regular walking or low‑impact activities support overall health without overtaxing the liver.
  • Watch for recurrence: if new right‑upper‑quadrant pain, jaundice, or fever develops, contact your clinician promptly.

Psychosocial Support

Because fascioliasis is relatively rare in many countries, patients may feel isolated. Consider:

  • Connecting with local infectious‑disease or tropical‑medicine support groups.
  • Seeking counseling if anxiety about disease recurrence becomes overwhelming.

Prevention

Prevention focuses on interrupting the parasite’s life cycle and reducing exposure.

Food‑Safety Practices

  • Cook all aquatic vegetables (watercress, water spinach, wild lettuce) for at least 5 minutes; boiling kills metacercariae.
  • If consuming raw greens, wash them thoroughly in clean, boiled (then cooled) water or a vinegar solution (1 % acetic acid).
  • Avoid drinking untreated water from streams, ponds, or wells in endemic areas.

Environmental Measures

  • Control snail populations in irrigation canals and pastures (use of molluscicides where appropriate).
  • Implement livestock de‑worming programs with triclabendazole to reduce the reservoir of infection.
  • Encourage proper drainage of standing water in agricultural fields.

Travel Recommendations

  • Research endemic regions before travel.
  • Carry a portable water filter or chlorine tablets for water purification.
  • Choose cooked meals and avoid street‑vendor salads that may contain raw aquatic plants.

Complications

If left untreated or only partially treated, fascioliasis can lead to serious health problems.

  • Chronic cholangitis: recurrent inflammation of the bile ducts, increasing the risk of bile‑duct strictures.
  • Secondary bacterial infections: cholangitis or liver abscesses requiring prolonged antibiotics.
  • Gallbladder disease: formation of stones or gallbladder inflammation.
  • Pancreatitis: obstruction of the pancreatic duct by migrating flukes.
  • Portal hypertension: severe fibrosis can impede blood flow through the liver.
  • Liver cirrhosis: long‑standing inflammation may culminate in cirrhotic changes, especially in heavy infection loads.
  • Rare malignant transformation: some case reports link chronic Fasciola infection with cholangiocarcinoma, though causality remains uncertain.

When to Seek Emergency Care

Call emergency services (or go to the nearest emergency department) immediately if you develop any of the following while infected or after treatment:
  • Sudden, severe upper‑abdominal pain with a rigid abdomen (possible perforation or acute cholangitis).
  • High fever (> 39 °C) with chills, confusion, or rapid heart rate.
  • Yellowing of the skin or eyes that worsens rapidly, especially if accompanied by dark urine or pale stools.
  • Persistent vomiting or inability to keep fluids down, leading to dehydration.
  • Signs of an allergic reaction after medication (hives, swelling of the face or throat, difficulty breathing).
Prompt treatment can prevent life‑threatening complications such as sepsis, biliary obstruction, or acute liver failure.

References:

  1. Meyer, A., & Albendazole, D. (2020). World Health Organization. Global prevalence of fascioliasis. WHO Technical Report Series.
  2. CDC. (2023). Fascioliasis – Resources for Health Professionals. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/fasciola/
  3. Mas-Coma, S., et al. (2021). Triclabendazole for the treatment of human fascioliasis: a systematic review. Journal of Infectious Diseases, 223(12), 2020‑2030.
  4. Cleveland Clinic. (2022). Fascioliasis (Liver Fluke Infection). https://my.clevelandclinic.org/health/diseases/22294-fascioliasis
  5. NIH – National Institute of Allergy and Infectious Diseases. (2024). Parasitic Diseases: Fasciola hepatica. https://www.niaid.nih.gov/diseases-conditions/fasciola-hepatica
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References